Literature DB >> 16785995

Directional sensing of a phorbol ester gradient requires CD44 and is regulated by CD44 phosphorylation.

G Tzircotis1, R F Thorne, C M Isacke.   

Abstract

Cancer progression is associated with enhanced directional cell migration, both of the tumour cells invading into the stroma and stromal cells infiltrating the tumour site. In cell-based assays to study directional cell migration, phorbol esters are frequently used as a chemotactic agent. However, the molecular mechanism by which these activators of protein kinase C (PKC) result in the establishment of a polarized migratory phenotype is not known. Here we show that CD44 expression is essential for chemotaxis towards a phorbol ester gradient. In an investigation of CD44 phosphorylation kinetics in resting and stimulated cells, Ser316 was identified as a novel site of phosphorylation following activation of PKC. PKC does not phosphorylate Ser316 directly, but rather mediates the activation of downstream Ser316 kinase(s). In transfection studies, a phosphorylation-deficient Ser316 mutant was shown to act in a dominant-negative fashion to impair chemotaxis mediated by endogenous CD44 in response to a phorbol ester gradient. Importantly, this mutation had no effect on random cell motility or the ability of cells to migrate directionally towards a cocktail of chemoattractants. These studies demonstrate that CD44 functions to provide directional cues to migrating cells without affecting the motility apparatus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16785995     DOI: 10.1038/sj.onc.1209724

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  6 in total

1.  Glycoprotein capture and quantitative phosphoproteomics indicate coordinated regulation of cell migration upon lysophosphatidic acid stimulation.

Authors:  Nina Mäusbacher; Thiemo B Schreiber; Henrik Daub
Journal:  Mol Cell Proteomics       Date:  2010-07-16       Impact factor: 5.911

Review 2.  Hyaluronan: a constitutive regulator of chemoresistance and malignancy in cancer cells.

Authors:  Bryan P Toole; Mark G Slomiany
Journal:  Semin Cancer Biol       Date:  2008-03-26       Impact factor: 15.707

3.  An integrated phosphoproteomics work flow reveals extensive network regulation in early lysophosphatidic acid signaling.

Authors:  Thiemo B Schreiber; Nina Mäusbacher; György Kéri; Jürgen Cox; Henrik Daub
Journal:  Mol Cell Proteomics       Date:  2010-01-12       Impact factor: 5.911

4.  The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition.

Authors:  Samudra K Dissanayake; Michael Wade; Carrie E Johnson; Michael P O'Connell; Poloko D Leotlela; Amanda D French; Kavita V Shah; Kyle J Hewitt; Devin T Rosenthal; Fred E Indig; Yuan Jiang; Brian J Nickoloff; Dennis D Taub; Jeffrey M Trent; Randall T Moon; Michael Bittner; Ashani T Weeraratna
Journal:  J Biol Chem       Date:  2007-04-10       Impact factor: 5.157

5.  CD44v4 is a major E-selectin ligand that mediates breast cancer cell transendothelial migration.

Authors:  Ke Zen; Dan-Qing Liu; Ya-Lan Guo; Chen Wang; Jun Shan; Ming Fang; Chen-Yu Zhang; Yuan Liu
Journal:  PLoS One       Date:  2008-03-19       Impact factor: 3.240

6.  sCD44 overexpression increases intraocular pressure and aqueous outflow resistance.

Authors:  Michael Giovingo; Michael Nolan; Ryan McCarty; Iok-Hou Pang; Abbot F Clark; Rachel M Beverley; Steven Schwartz; W Daniel Stamer; Loyal Walker; Algis Grybauskas; Kevin Skuran; Paulius V Kuprys; Beatrice Y J T Yue; Paul A Knepper
Journal:  Mol Vis       Date:  2013-11-01       Impact factor: 2.367

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.